BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28393474)

  • 21. The promises and challenges of human brain organoids as models of neuropsychiatric disease.
    Quadrato G; Brown J; Arlotta P
    Nat Med; 2016 Nov; 22(11):1220-1228. PubMed ID: 27783065
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Ishii T; Ishikawa M; Fujimori K; Maeda T; Kushima I; Arioka Y; Mori D; Nakatake Y; Yamagata B; Nio S; Kato TA; Yang N; Wernig M; Kanba S; Mimura M; Ozaki N; Okano H
    eNeuro; 2019; 6(5):. PubMed ID: 31540999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Psychiatric Disorder Biology with Stem Cells.
    Das D; Feuer K; Wahbeh M; Avramopoulos D
    Curr Psychiatry Rep; 2020 Apr; 22(5):24. PubMed ID: 32318888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular models to study bipolar disorder: A systematic review.
    Viswanath B; Jose SP; Squassina A; Thirthalli J; Purushottam M; Mukherjee O; Vladimirov V; Patrinos GP; Del Zompo M; Jain S
    J Affect Disord; 2015 Sep; 184():36-50. PubMed ID: 26070045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons.
    Habela CW; Song H; Ming GL
    Mol Cell Neurosci; 2016 Jun; 73():52-62. PubMed ID: 26655799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling neuropsychiatric disorders using human induced pluripotent stem cells.
    Wang M; Zhang L; Gage FH
    Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental health dished up-the use of iPSC models in neuropsychiatric research.
    McNeill RV; Ziegler GC; Radtke F; Nieberler M; Lesch KP; Kittel-Schneider S
    J Neural Transm (Vienna); 2020 Nov; 127(11):1547-1568. PubMed ID: 32377792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cell (iPSC) models of bipolar disorder.
    O'Shea KS; McInnis MG
    Neuropsychopharmacology; 2015 Jan; 40(1):248-9. PubMed ID: 25482177
    [No Abstract]   [Full Text] [Related]  

  • 30. Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons.
    Shum C; Macedo SC; Warre-Cornish K; Cocks G; Price J; Srivastava DP
    Horm Behav; 2015 Aug; 74():228-42. PubMed ID: 26143621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells.
    Lemonnier T; Blanchard S; Toli D; Roy E; Bigou S; Froissart R; Rouvet I; Vitry S; Heard JM; Bohl D
    Hum Mol Genet; 2011 Sep; 20(18):3653-66. PubMed ID: 21685203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astrocyte-Derived Exosomes in an iPSC Model of Bipolar Disorder.
    Attili D; Schill DJ; DeLong CJ; Lim KC; Jiang G; Campbell KF; Walker K; Laszczyk A; McInnis MG; O'Shea KS
    Adv Neurobiol; 2020; 25():219-235. PubMed ID: 32578149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism.
    St Clair D; Johnstone M
    Philos Trans R Soc Lond B Biol Sci; 2018 Mar; 373(1742):. PubMed ID: 29352035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons.
    Vadodaria KC; Stern S; Marchetto MC; Gage FH
    Cell Tissue Res; 2018 Jan; 371(1):161-170. PubMed ID: 28812143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological studies using iPSC-derived neurons from patients with schizophrenia].
    Nakazawa T
    Nihon Yakurigaku Zasshi; 2021; 156(4):220-223. PubMed ID: 34193699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders.
    Petit I; Kesner NS; Karry R; Robicsek O; Aberdam E; Müller FJ; Aberdam D; Ben-Shachar D
    Stem Cell Res; 2012 Jan; 8(1):134-40. PubMed ID: 22099027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation.
    D'Aiuto L; Zhi Y; Kumar Das D; Wilcox MR; Johnson JW; McClain L; MacDonald ML; Di Maio R; Schurdak ME; Piazza P; Viggiano L; Sweet R; Kinchington PR; Bhattacharjee AG; Yolken R; Nimgaonkar VL
    Organogenesis; 2014; 10(4):365-77. PubMed ID: 25629202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish.
    Hoffmann A; Sportelli V; Ziller M; Spengler D
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29517996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.
    Berridge MJ
    Cell Tissue Res; 2014 Aug; 357(2):477-92. PubMed ID: 24577622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.